logo
States sue Trump, saying he is intimidating hospitals over gender-affirming care for youth

States sue Trump, saying he is intimidating hospitals over gender-affirming care for youth

Seventeen Democratic officials accused President Donald Trump's administration of unlawfully intimidating health care providers into stopping gender-affirming care for transgender youth in a lawsuit filed Friday.
The complaint comes after a month in which at least eight major hospitals and hospital systems — all in states where the care is allowed under state law — announced they were stopping or restricting the care. The latest announcement came Thursday from UI Health in Chicago.
Trump's administration announced in July that it was sending subpoenas to providers and focusing on investigating them for fraud. It later boasted in a news release that hospitals are halting treatments.
The Democratic officials say Trump's policies are an attempt to impose a nationwide ban on the treatment for people under 19 — and that's unlawful because there's no federal statute that bans providing the care to minors. The suit was filed by attorneys general from 15 states and the District of Columbia, plus the governor of Pennsylvania, in U.S. District Court in Boston.
'The federal government is running a cruel and targeted harassment campaign against providers who offer lawful, lifesaving care to children,' New York Attorney General Letitia James said in a statement.
Trump and others who oppose the care say that it makes permanent changes that people who receive it could come to regret — and maintain that it's being driven by questionable science.
Since 2021, 28 states with Republican-controlled legislatures have adopted policies to ban or restrict gender-affirming care for minors. In June, the U.S. Supreme Court ruled that states have a right to enforce those laws.
The medical centers are responding to political and legal pressure
The Center for Transyouth Health and Development at Children's Hospital Los Angeles, the biggest public provider of gender-affirming care for children in teens in the U.S., closed in July.
At least seven other major hospitals and health systems have made similar announcements, including Children's National in Washington D.C., UChicago Medicine and Yale New Haven Health.
Kaiser Permanente, which operates in California and several other states, said it would pause gender-affirming surgeries for those under 19 as of the end of August, but would continue hormone therapy.
Connecticut Children's Medical Center cited 'an increasingly complex and evolving landscape" for winding down care.
Other hospitals, including Penn State, had already made similar decisions since Trump returned to office in January.
Alex Sheldon, executive director of GLMA, an organization that advocates for health care equity for LGBTQ+ people, said the health systems have pulled back the services for legal reasons, not medical ones.
'Not once has a hospital said they are ending care because it is not medically sound,' Sheldon said.
Trump's administration has targeted the care in multiple ways
Trump devoted a lot of attention to transgender people in his campaign last year as part of a growing pushback from conservatives as transgender people have gained visibility and acceptance on some fronts. Trump criticized gender-affirming care, transgender women in women's sports, and transgender women's use of women's facilities such as restrooms.
On his inauguration day in January, Trump signed an executive order defining the sexes as only male and female for government purposes, setting the tone for a cascade of actions that affect transgender people. About a week later, Trump called to stop using federal money, including from Medicaid, for gender-affirming care for those under 19.
About half of U.S. adults approve of Trump's handling of transgender issues, an AP-NORC poll found. But the American Medical Association says that gender is on a spectrum, and the group opposes policies that restrict access to gender-affirming health care.
Gender-affirming care includes a range of medical and mental health services to support a person's gender identity, including when it's different from the sex they were assigned at birth. It includes counseling and treatment with medications that block puberty, and hormone therapy to produce physical changes, as well as surgery, which is rare for minors.
In March, a judge paused enforcement of the ban on government spending for care.
The court ruling didn't stop other federal government action
In April, Attorney General Pam Bondi directed government investigators to focus on providers who continue to offer gender-affirming care for transgender youth. 'Under my leadership, the Department of Justice will bring these practices to an end," she wrote.
In May, the Department of Health and Human Services issued a report discouraging medical interventions for transgender youth and instead focusing solely on talk therapy. The report questions adolescents' capacity to consent to life-changing treatments that could result in future infertility. The administration has not said who wrote the report, which has been deeply criticized by LGBTQ+ advocates.
In June, a Justice Department memo called for prioritizing civil investigations of those who provide the treatment.
In July, Justice Department announced it had sent more than 20 subpoenas to doctors and clinics involved in gender-affirming care for youth, saying they were part of investigations of health care fraud, false statements and other possible wrongdoing.
And in a statement last week, the White House celebrated decisions to end gender-affirming care, which it called a 'barbaric, pseudoscientific practice'
Families worry about accessing care
Kristen Salvatore's 15-year-old child started hormone therapy late last year at Penn State Health. Salvatore said in an interview with The Associated Press before the lawsuit was announced that it was a major factor in reduced signs of anxiety and depression. Last month, the family received official notice from the health system that it would no longer offer the hormones for patients under 19 after July 31, though talk therapy can continue.
Salvatore has been struggling to find a place that's not hours away from their Mechanicsburg, Pennsylvania, home that would provide the hormones and accept Medicaid coverage.
'I'm walking around blind with no guidance, and whatever breadcrumbs I was given are to a dead-end alleyway,' she said.
The family has enough testosterone stockpiled to last until January. But if they can't find a new provider by then, Salvatore's child could risk detransitioning, she said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Dr. Mehmet Oz says applications for $50 billion rural hospital fund will go out "in early September"
Dr. Mehmet Oz says applications for $50 billion rural hospital fund will go out "in early September"

CBS News

time4 hours ago

  • CBS News

Dr. Mehmet Oz says applications for $50 billion rural hospital fund will go out "in early September"

Washington — Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz said Sunday that applications for a fund for rural hospitals will go out in "early September" in the wake of Medicaid cuts in President Trump's signature piece of legislation passed by Congress last month. "We're putting $50 billion. The president wants this, the Congress wants this," Oz said on "Face the Nation with Margaret Brennan." Mr. Trump signed the so-called "big, beautiful bill" into law last month, which included a number of his second-term priorities from tax cuts to increased spending on border security, defense and energy production. The legislation was paid for in part by significant cuts to health care programs, like Medicaid, which provides government-sponsored health care for low-income and disabled Americans. Among the cuts to Medicaid, the new law will lower provider taxes, which states use to help fund their portion of Medicaid costs. Lawmakers sought to supplement the cuts with a rural hospital stabilization fund after some GOP senators expressed concern over how rural hospitals could be impacted by the Medicaid restrictions, allocating $50 billion for rural hospitals. Oz outlined that rural hospitals will receive applications for the fund in early September. He said the money is designed to help with "workforce development, right-sizing the system and using technology to provide things like telehealth that can change the world." "Imagine if we can change the way we think about the delivery of health and make it more about getting people healthy who can thrive and flourish and be fully present in their own lives and as Americans," Oz said. The new law will also make changes to Medicaid work requirements for some able-bodied adults, along with more frequent eligibility checks. The Congressional Budget Office estimated that the legislation would result in 11.8 million Americans losing health coverage under Medicaid over the next decade. Oz touted the work requirements, saying "every Democratic president and Republican president has said that the foundation of a healthy welfare system, a social system of support, is work." He outlined that the requirements can also be met through community engagement, education and in caretaking roles, and that the administration began pursuing pilot programs when the bill was signed to demonstrate how technology can support the changes. But Brennan noted that according to KFF Health Policy, 92% of adult Medicaid recipients already are working or are caregivers or qualify for other exceptions. Oz said "they're fine." "We want to help connect you to the job market and get you into work," Oz said of people who are considered able-bodied. "The goal of health care insurance is to catalyze action in the right direction, to get you healthier, to give you agency over the future, so you recognize you matter, and you should have a job, therefore, to go out and change the world."

Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time
Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time

Wall Street Journal

time8 hours ago

  • Wall Street Journal

Why Drug Prices for Some Big Medicines Will Remain High for a Longer Time

Thousands of Medicare recipients will have to wait longer to get some price relief on the expensive cancer drugs they depend on for treatment, while others might not get any reprieve at all. Two little-known provisions in the One Big Beautiful Bill Act signed by President Trump in July will delay Medicare price negotiations for some of the biggest-selling drugs in the world, including Merck's Keytruda, which is used to treat cancer and had $17.9 billion in U.S. sales in 2024. Other drugs, such as Johnson & Johnson's Darzalex, will be excluded entirely.

White House backs away from IVF mandate despite Trump's campaign pledge, Washington Post
White House backs away from IVF mandate despite Trump's campaign pledge, Washington Post

USA Today

time9 hours ago

  • USA Today

White House backs away from IVF mandate despite Trump's campaign pledge, Washington Post

WASHINGTON − The White House has no current plans to mandate insurance coverage for in vitro fertilization, despite President Donald Trump's campaign promise to expand access to fertility treatments, The Washington Post reported on Saturday. Trump signed an executive order earlier this year directing the government to expand access to IVF and reduce the costs of the popular fertility treatment. More: Some workers are job hopping for fertility benefits. Employers are trying to keep up. White House officials say expanding IVF access remains a priority, but legal constraints prevent mandating coverage without Congressional approval, and no bill is currently planned, the Post reported. Officials did not immediately respond to a request for comment by USA TODAY. Contributing: Francesca Chambers

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store